176 related articles for article (PubMed ID: 16247094)
1. What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?
Sudlow C
CMAJ; 2005 Oct; 173(9):1024-6. PubMed ID: 16247094
[No Abstract] [Full Text] [Related]
2. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
Scheen AJ
Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
[TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
Diener HC
MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
[No Abstract] [Full Text] [Related]
4. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Liao JK
Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
Diener HC; Weber R; Weimar C; Röther J
Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
[No Abstract] [Full Text] [Related]
6. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
7. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
Verro P; Gorelick PB; Nguyen D
Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
9. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
[TBL] [Abstract][Full Text] [Related]
12. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Thijs V; Lemmens R; Fieuws S
Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
[TBL] [Abstract][Full Text] [Related]
13. [PRoFESS study presented. Change in secondary prevention].
MMW Fortschr Med; 2003 May; 145 Suppl 2():96-7. PubMed ID: 14579494
[No Abstract] [Full Text] [Related]
14. Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
Lenz TL; Hilleman DE
Ann Pharmacother; 2000 Nov; 34(11):1283-90. PubMed ID: 11098344
[TBL] [Abstract][Full Text] [Related]
15. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
16. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
17. Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
Crown N; Mysak T
Am J Health Syst Pharm; 2010 May; 67(9):728-33. PubMed ID: 20410547
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
19. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
